Search for: "Mylan, Inc." Results 281 - 300 of 587
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jun 2007, 3:27 am
According to the Houston Chronicle, Texas is suing three drug companies alleging the companies took advantage of the Medicare system and cost the state tens of millions of dollars in overpayments.The lawsuit was filed against Sandoz, Inc. of New Jersey, Mylan Laboratories of Pennsylvania and Teva Pharmaceuticals, Inc., along with some of their subsidiaries. [read post]
6 Oct 2009, 12:41 am
Mylan Pharmaceuticals Inc. et al., 1-08-cv-00889(DED October 2, 2009, Memorandum Order) (Robinson, J.) [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
”  Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
”  Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
5 Oct 2020, 10:25 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
14 May 2019, 11:24 am by Lawrence B. Ebert
Mylan Labs., Inc., 464 F.3d 1286,1289 (Fed. [read post]
3 Sep 2008, 11:00 am
Plaintiffs are citizens of Louisiana, and they named both Mylan Pharmaceuticals (a citizen of West Virginia) and Mylan, Inc. [read post]
31 Oct 2011, 6:46 am by Steve McConnell
They are also now big, big litigation.You might think that last week's decision in Hughes v Mylan, Inc., 2011 U.S. [read post]
2 Mar 2010, 5:10 am by Lawrence B. Ebert
Mylan Labs., Inc., 520 F.3d 1358, 1364–65 (Fed. [read post]
14 Apr 2014, 3:51 pm by Lyle Denniston
The generic firms — Sandoz Inc., Momenta Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., and Natco Pharma Ltd. [read post]
5 Jul 2020, 10:30 am by Magdaleen Jooste
Court of Appeals for the Federal Circuit (CAFC) affirmed a Patent Trial and Appeal Board (PTAB) decision that certain claims of Nike, Inc. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
The CA upheld this in Neurim v Generics UK Limited (t/a Mylan) [2022] EWCA Civ 370. [read post]
The following consumer protection actions made headlines this week: Mylan Reaches $465 Million Settlement Over Medicaid Classification On October 7, 2016, Mylan Inc. announced that it had agreed to pay $465 million to resolve a DOJ investigation into Mylan’s classification of EpiPen as a generic drug that resulted in Medicaid and Medicare receiving a significantly smaller rebate on every prescription since 2007. [read post]